MoneyWorks4Me

The revenue for the March 2023 quarter is pegged at Rs. 825.60 millions, about 16.70% up against Rs. 707.48 millions recorded during the year-ago period.Modest increase of 21.91% in the Net Profit was reported from. 143.52 millions to Rs. 174.97  millions.Operating profit for the quarter ended March 2023 rose to 260.92 millions as compared to 205.52 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 825.60 707.48 16.70 3115.29 2727.98 14.20 3115.29 2727.98 14.20
Other Income 28.10 51.69 -45.64 98.08 90.80 8.02 98.08 90.80 8.02
PBIDT 260.92 205.52 26.96 846.96 817.28 3.63 846.96 817.28 3.63
Interest 0.57 0.52 9.62 1.35 0.95 42.11 1.35 0.95 42.11
PBDT 260.35 205.00 27.00 845.61 816.33 3.59 845.61 816.33 3.59
Depreciation 27.57 25.34 8.80 102.83 95.61 7.55 102.83 95.61 7.55
PBT 232.78 179.66 29.57 742.78 720.72 3.06 742.78 720.72 3.06
TAX 57.81 36.14 59.96 187.51 175.61 6.78 187.51 175.61 6.78
Deferred Tax 5.52 -3.52 -256.82 4.97 -4.56 -208.99 4.97 -4.56 -208.99
PAT 174.97 143.52 21.91 555.27 545.11 1.86 555.27 545.11 1.86
Equity 223.65 223.60 0.02 223.65 223.60 0.02 223.65 223.60 0.02
PBIDTM(%) 31.60 29.05 8.79 27.19 29.96 -9.25 27.19 29.96 -9.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..